Organization
UPMC Cancer Center - Hillman Cancer Center
4 abstracts
Abstract
Retrospective study of ivosidenib for patients with recurrent IDH mutant gliomas.Org: University of Pittsburgh, University of Pittsburgh Cancer Institute, UPMC Cancer Center - Hillman Cancer Center,
Abstract
A phase 2 evaluation of daratumumab-based induction therapy in patients with multiple myeloma with severe renal insufficiency.Org: Emory University School of Medicine and Winship Cancer Institute, UPMC Cancer Center - Hillman Cancer Center, Winship Cancer Institute of Emory University,
Abstract
A phase III randomized controlled trial of a stepped collaborative care intervention versus standard of care.Org: Univ of Pittsburgh, University of Pittsburgh Medical Center, University of Pittsburg School of Medicine Eye and Ear Institute, UPMC Cancer Center - Hillman Cancer Center, University of Pittsburgh Medical Center Cancer Center,
Abstract
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.Org: UPMC Cancer Center - Hillman Cancer Center, Hillman Cancer Center, Pittsburgh, PA, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA,